Clinical Trial Update: Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the impact of different budesonide doses on bone metabolism markers in children with asthma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide (Pulmicort) (budesonide)

Snippet

Sponsor: Medical University of Lodz | Conditions: Asthma | Phase 4 | Status: COMPLETED